AQR Capital Management - REVANCE THERAPEUTICS INC ownership

REVANCE THERAPEUTICS INC's ticker is RVNC and the CUSIP is 761330109. A total of 159 filers reported holding REVANCE THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is 2.29 and the average weighting 0.1%.

Quarter-by-quarter ownership
AQR Capital Management ownership history of REVANCE THERAPEUTICS INC
ValueSharesWeighting
Q2 2023$341,255
-25.4%
13,483
-5.0%
0.00%0.0%
Q1 2023$457,382
+69.4%
14,200
+46.5%
0.00%0.0%
Q3 2021$270,000
-5.9%
9,6910.0%0.00%
Q2 2021$287,000
-36.6%
9,691
-40.2%
0.00%
-100.0%
Q1 2021$453,000
-9.2%
16,208
-7.9%
0.00%0.0%
Q4 2020$499,000
-1.4%
17,594
-12.6%
0.00%0.0%
Q3 2020$506,000
+55.7%
20,141
+51.4%
0.00%0.0%
Q2 2020$325,000
+61.7%
13,303
+64.5%
0.00%
Q3 2018$201,000
-44.8%
8,086
-39.0%
0.00%
Q2 2018$364,000
-10.6%
13,249
+0.3%
0.00%
Q1 2018$407,000
-11.5%
13,210
+2.8%
0.00%
Q4 2017$460,000
+60.8%
12,854
+23.7%
0.00%
Q3 2017$286,000
+74.4%
10,391
-13.9%
0.00%
Q2 2016$164,000
-38.1%
12,073
-20.5%
0.00%
Q1 2016$265,000
-38.1%
15,187
+21.3%
0.00%
-100.0%
Q4 2015$428,00012,5210.00%
Other shareholders
REVANCE THERAPEUTICS INC shareholders Q3 2021
NameSharesValueWeighting ↓
NovaQuest Capital Management, L.L.C. 1,558,426$48,000,00065.50%
Essex Woodlands Management, Inc. 3,842,047$118,335,00025.90%
Rhenman & Partners Asset Management AB 203,181$6,258,0000.77%
EAM Global Investors LLC 44,898$1,383,0000.72%
Fosun International Ltd 319,313$9,835,0000.62%
EAM Investors, LLC 113,096$3,483,0000.58%
ArrowMark Colorado Holdings LLC 1,735,699$53,460,0000.53%
Perceptive Advisors 618,957$19,064,0000.53%
ESSEX INVESTMENT MANAGEMENT CO LLC 111,360$3,430,0000.45%
Schonfeld Strategic Advisors LLC 83,700$2,578,0000.19%
View complete list of REVANCE THERAPEUTICS INC shareholders